Dr. Alvaro Rios, M.D.
What this data tells you about Dr. Rios
Dr. Alvaro Rios is a cardiovascular disease in Burleson, TX, with 20 years in practice. Based on federal Medicare data, Dr. Rios performed 3,277 Medicare services across 2,140 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rios received a total of $7,262 from 45 pharmaceutical and/or device companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rios is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 456 | $86 | $231 |
| Electrocardiogram (EKG), 12-lead | 371 | $10 | $42 |
| Remote pacemaker monitoring, 90 days | 282 | $20 | $74 |
| Remote pacemaker/defibrillator monitoring, 90 days | 281 | $16 | $66 |
| Regadenoson injection (Lexiscan) for heart stress test | 274 | $43 | $120 |
| Prothrombin time test (blood clotting) | 185 | $4 | $13 |
| Office visit, established patient (20-29 min) | 184 | $53 | $156 |
| Hospital follow-up visit, high complexity | 152 | $91 | $223 |
| Office visit, established patient, complex (40-54 min) | 147 | $123 | $310 |
| Echocardiogram, transthoracic | 127 | $143 | $471 |
| Ultrasound of both sides of head and neck blood flow | 103 | $95 | $397 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 76 | $48 | $196 |
| Initial hospital admission, high complexity | 66 | $131 | $434 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 50 | $132 | $214 |
| Ultrasound of leg arteries or artery grafts | 47 | $130 | $566 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 46 | $341 | $1,111 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 44 | $77 | $360 |
| Hospital follow-up visit, moderate complexity | 38 | $62 | $155 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 37 | $17 | $44 |
| Ultrasound study of arm and leg arteries | 34 | $41 | $210 |
| New patient office visit (45-59 min) | 30 | $114 | $355 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 30 | $754 | $1,140 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 29 | $1,051 | $2,490 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 27 | $14 | $20 |
| Chronic care management, first 20 min/month | 23 | $49 | $95 |
| New patient office visit, complex (60-74 min) | 22 | $146 | $442 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 20 | $20 | $75 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 20 | $654 | $900 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $10 | $150 |
| Programming of dual lead pacemaker system | 18 | $55 | $131 |
| Hospital follow-up visit, low complexity | 15 | $36 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $2 | $30 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $98 | $469 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rios is a electrophysiology & remote specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rios experienced with office visit, established patient (30-39 min)?
Does Dr. Rios receive payments from pharmaceutical companies?
How do Dr. Rios's costs compare to other cardiovascular diseases in Burleson?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology